Treatment of severe covid-19 with interleukin 6 receptor inhibition

被引：1
|
作者：
Rajasundaram, Skanda [1 ]
Burgess, Stephen [2 ]
Gill, Dipender [3 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Univ Cambridge, Cambridge, England
[3] Imperial Coll London, Dipender Gill, London SW7 2BX, England
来源：
BMJ MEDICINE | 2022年 / 1卷 / 01期
基金：
英国惠康基金;
关键词：
D O I：
10.1136/bmjmed-2022-000144
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Interleukin-6 as prognosticator in patients with COVID-19
    Grifoni, Elisa
    Valoriani, Alice
    Cei, Francesco
    Lamanna, Roberta
    Gelli, Anna Maria Grazia
    Ciambotti, Benedetta
    Vannucchi, Vieri
    Moroni, Federico
    Pelagatti, Lorenzo
    Tarquini, Roberto
    Landini, Giancarlo
    Vanni, Simone
    Masotti, Luca
    [J]. JOURNAL OF INFECTION, 2020, 81 (03) : 466 - 467
  • [32] The conundrum of interleukin-6 blockade in COVID-19
    Campochiaro, Corrado
    Dagna, Lorenzo
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (10): : E579 - E580
  • [33] Tocilizumab is recommended for the treatment of severe COVID-19
    Zhou, Yonggang
    Wei, Haiming
    [J]. EBIOMEDICINE, 2020, 61
  • [34] Dexamethasone for treatment of severe COVID-19, a surprise?
    Hany Hasan Elsayed
    [J]. The Cardiothoracic Surgeon, 28
  • [35] Treatment options for patients with severe COVID-19
    Morishita, Momoko
    Hojo, Masayuki
    [J]. GLOBAL HEALTH & MEDICINE, 2023, 5 (02): : 99 - 105
  • [36] Convalescent Plasma for the Treatment of Severe COVID-19
    Franchini, Massimo
    Liumbruno, Giancarlo Maria
    [J]. BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 31 - 38
  • [37] Dexamethasone for treatment of severe COVID-19, a surprise?
    Elsayed, Hany Hasan
    [J]. CARDIOTHORACIC SURGEON, 2020, 28 (01):
  • [38] Treatment of severe COVID-19: an evolving paradigm
    McCarthy, Matthew W.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (17) : 1887 - 1891
  • [39] The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series
    Tadepalli, Satish
    Vanjarapu, Jagan Mohan Rao
    De Dona, Anna
    Cheriyath, Pramil
    Nookala, Vinod
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [40] Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'
    Winkler, Martin Sebastian
    Korsten, Peter
    Binder, Claudia
    Tampe, Bjoern
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08)
12345